Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.
ATR激酶抑制剂Elimusertib单药或联合治疗对具有DNA损伤反应通路和其他基因组改变的肿瘤的疗效
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-24-0884
Varadarajan Kaushik, Cruz Pico Christian X, Evans Kurt W, Raso Maria Gabriela, Rizvi Yasmeen Qamar, Zheng Xiaofeng, Chachad Dhruv, DiPeri Timothy P, Wang Bailiang, Scott Stephen M, Zhao Ming, Akcakanat Argun, Wengner Antje M, Yap Timothy A, Meric-Bernstam Funda